Femasys

$Femasys(FEMY)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-032014  Act: 34  Size: 188 KB 网页链接

$Femasys(FEMY)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001140361-25-032799  Act: 33  Size: 452 KB 网页链接

$Femasys(FEMY)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001137439-25-000998  Act: 34  Size: 6 KB 网页链接

$Femasys(FEMY)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-029065  Act: 34  Size: 183 KB 网页链接

$Femasys(FEMY)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-084691  Act: 34  Size: 17 KB 网页链接

$Femasys(FEMY)$ 8-K Current report, item 3.01 Accession Number: 0001140361-25-026431  Act: 34  Size: 158 KB 网页链接

$Femasys(FEMY)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001140361-25-029864  Act: 34  Size: 5 MB 网页链接

来源：环球市场播报
　　美股周二早盘，生物技术公司Femasys（FEMY）股价重挫35.7%，此前该公司宣布通过公开发行募集800万美元资金，所筹资金将用于支持该公司的商业扩张和产品开发计划。

$Femasys(FEMY)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001140361-25-031990  Act: 33  Size: 711 KB 网页链接

$Femasys(FEMY)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-25-029860  Act: 34  Size: 396 KB 网页链接

$Femasys(FEMY)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001140361-25-032230  Act: 33  Size: 1 MB 网页链接

$Femasys(FEMY)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002740  Act: 33  Size: 1 KB 网页链接

$Femasys(FEMY)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001140361-25-032806  Act: 34  Size: 884 KB 网页链接

$Femasys(FEMY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-033197  Size: 7 KB 网页链接

$Femasys(FEMY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-033200  Size: 6 KB 网页链接